A potent anticancer agent of shikonin derivative targeting tubulin.
Baloch SK, Ma L, Xu GH, Bai LF, Zhao H, Tang CY, Pang YJ, Yang RW, Wang XM, Lu GH, Yang YH.
Baloch SK, et al. Among authors: pang yj.
Chirality. 2015 Mar;27(3):274-80. doi: 10.1002/chir.22425. Epub 2015 Feb 6.
Chirality. 2015.
PMID: 25663187